ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Current studies on the occurrence of secondary drug resistance include amplification and increased expression of BCR-ABL fusion genes, multidrug resistance gene overexpression, and drug resistance of CML stem cells.